In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point
My doctor said it best, There aint no fat old people. As part of the Barkley ambassadorship, Ro said it will collaborate with his new production company, Round Mound Media, on projects for obesity education, reflecting a shared commitment to advancing health equity and reaching communities that have historically faced barriers to healthcare. The collaboration, Ro said, will raise awareness around the efficacy of GLP-1s, share updates on Barkleys own journey, and help more people feel empowered to take control of their weight loss journey and overall health.
[DOI] [PMC free article] [PubMed] [Google Scholar] 38.Bolner A., Pilleri M., De Riva V., Nordera G.P
All C-APCs are displayed in Addendum J to this CY 2026 OPPS/ASC final rule with comment period (which is available via the internet on the CMS website)
3 sessions per week 25 to 30 minutes per session 2 sets of each exercise 1215 controlled reps per set Increase resistance by the smallest available jump when the last rep feels easy Strength training is essential to preserve, activate, and build muscle
Cycling conditions: 98 C for 1 min